CD4+CD25+ regulatory T cells and graft-versus-host disease

被引:41
|
作者
Hoffmann, P
Edinger, M
机构
[1] Univ Hosp Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany
[2] Univ Hosp Regensburg, Inst Immunol, D-93053 Regensburg, Germany
关键词
D O I
10.1053/j.seminhematol.2005.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral suppression of autoreactive T cells by specialized T-cell populations is one of several mechanisms ensuring self-tolerance within the adaptive immune system. Thymus-derived CD4+CD25+ T cells expressing the transcriptional repressor FOXP3 mediate such immunoregulatory functions and are pivotal for the prevention of autoimmunity. As peripheral tolerance induction is a prerequisite for successful treatment outcome after allogeneic hematopoietic stem cell transplantation (HSCT), the role of CD4 +CD25+ T cells in transplantation models and clinical trials is now under investigation in many laboratories. Here we summarize recent results regarding protection from graft-versus-host disease (GVHD) by adoptively transferred CD4+CD25+ T cells in mice and discuss early findings from clinical studies in HSCT. © 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 50 条
  • [1] CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
    Cohen, JL
    Trenado, A
    Vasey, D
    Klatzmann, D
    Salomon, BL
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03): : 401 - 406
  • [2] Maintenance of CD8+T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease
    Juyang Kim
    Hye J Kim
    Woon S Choi
    Seok H Nam
    Hong R Cho
    Byungsuk Kwon
    Experimental & Molecular Medicine, 2006, 38 : 494 - 501
  • [4] Efficient Treatment of Murine Acute Graft-Versus-Host Disease with In Vitro Expanded CD4+CD25+ Regulatory T Cells
    Boeld, Tina J.
    Doser, Kristina
    Lang-Schwarz, Corinna
    Huber, Elisabeth
    Andreesen, Reinhard
    Hoffmann, Petra
    Edinger, Matthias
    BLOOD, 2011, 118 (21) : 1287 - 1287
  • [5] Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease
    Kim, Juyang
    Kim, Hye J.
    Choi, Woon S.
    Nam, Seok H.
    Cho, Hong R.
    Kwon, Byungsuk
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2006, 38 (05): : 494 - 501
  • [6] Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
    Zorn, E
    Kim, HT
    Lee, SJ
    Floyd, BH
    Litsa, D
    Arumugarajah, S
    Bellucci, R
    Alyea, EP
    Antin, JH
    Soiffer, RJ
    Ritz, J
    BLOOD, 2005, 106 (08) : 2903 - 2911
  • [7] Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease
    Karakhanova, S
    Munder, M
    Sehneider, M
    Bonyhadi, M
    Ho, AD
    Goerner, M
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (03) : 336 - 349
  • [8] The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease
    Cohen, Jose L.
    Boyer, Olivier
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (05) : 580 - 585
  • [9] Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
    Zeiser, Robert
    Nguyen, Vu H.
    Hou, Jing-Zhou
    Beilhack, Andreas
    Zambricki, Elizabeth
    Buess, Martin
    Contag, Christopher H.
    Negrin, Robert S.
    BLOOD, 2007, 109 (05) : 2225 - 2233
  • [10] CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
    Matthias Edinger
    Petra Hoffmann
    Joerg Ermann
    Kathryn Drago
    C Garrison Fathman
    Samuel Strober
    Robert S Negrin
    Nature Medicine, 2003, 9 : 1144 - 1150